FDA Inspection
APIPHARMA d.o.oAPIPHARMA d.o.o – FDA Inspection, Mar 28, 2025
Record Details
This FDA Inspection record concerns APIPHARMA d.o.o, with an inspection on March 28, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 11e9c254-0fac-4394-aa94-56cdf77a2af2
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1265199
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
10- 21 CFR 211.103Actual vs. theoretical yields not determined
- 21 CFR 211.160(b)(3)Acceptance of drug products
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.170(b)Annual visual exams of drug products
- 21 CFR 211.166(a)Results not used for expiration dates, storage cond.
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.22(c)Approve or reject procedures or specs
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.111Establishment of time limitations
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of APIPHARMA d.o.o
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 26, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for APIPHARMA d.o.o
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.